Trevi Therapeutics, Inc. TRVI Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s total liabilities?
- Trevi Therapeutics, Inc. (TRVI) reported total liabilities of $7.48M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s total liabilities changed year-over-year?
- Trevi Therapeutics, Inc.'s total liabilities decreased by 0.9% year-over-year, from $7.55M to $7.48M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s total liabilities has grown at a -12.5% compound annual growth rate (CAGR), from $19.85M to $10.2M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.